Comparison of therapeutic effects of EGFR‐tyrosine kinase inhibitors on 19Del and L858R mutations in advanced lung adenocarcinoma and effect on cellular immune function

BACKGROUND: We compared the therapeutic effect of EGFR‐tyrosine kinase inhibitors (TKIs) on 19Del and L858R mutations in advanced lung adenocarcinoma on cellular immune function and explored the factors influencing the curative effect and prognosis. METHODS: Clinical efficacy in the selected 71 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Juan, Ben, Suqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792717/
https://www.ncbi.nlm.nih.gov/pubmed/29222872
http://dx.doi.org/10.1111/1759-7714.12568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792717/
https://www.ncbi.nlm.nih.gov/pubmed/29222872
http://dx.doi.org/10.1111/1759-7714.12568

Ejemplares similares